Filing Flows › Comparisons › STIM vs INFU
Neuronetics vs InfuSystem Holdings: STIM and INFU compared
Neuronetics is the larger company: $42.0M of revenue in its latest quarter (Q3 2026) against $37.6M for InfuSystem Holdings (Q3 2026). Neuronetics is growing faster (+12% against +3% a year earlier). InfuSystem Holdings is more profitable, with an operating margin of 12.6% against 1.3%.
Where the money goes: STIM and INFU
Neuronetics (STIM) · Q3 2026
Neuronetics, Q3 2026: revenue $42.0M (+12% year over year), operating margin 1.3%, net loss $1.6M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
InfuSystem Holdings (INFU) · Q3 2026
InfuSystem Holdings, Q3 2026: revenue $37.6M (+3% year over year), operating margin 12.6%, net earnings $3.2M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
| Neuronetics (STIM) | InfuSystem Holdings (INFU) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $42.0M | $37.6M |
| Revenue growth, Y/Y | +12% | +3% |
| Gross margin | — | 57.8% |
| Operating margin | 1.3% | 12.6% |
| Net earnings | −$1.6M | $3.2M |
| Net margin | -3.7% | 8.4% |
| Operating cash flow | $1.2M | $10.3M |
| Free cash flow | $768K | $10.3M |
Where the revenue comes from
Neuronetics
- Service: $26.2M (62%)
- NeuroStar: $15.8M (38%)
InfuSystem Holdings
- Patient Services: $25.8M (69%)
- Device Solutions: $11.8M (31%)
Questions
Which is bigger, Neuronetics or InfuSystem Holdings?
Neuronetics is the larger company: $42.0M of revenue in its latest quarter (Q3 2026) against $37.6M for InfuSystem Holdings (Q3 2026).
Is Neuronetics or InfuSystem Holdings growing faster?
Neuronetics is growing faster (+12% against +3% a year earlier).
Which is more profitable, Neuronetics or InfuSystem Holdings?
InfuSystem Holdings is more profitable, with an operating margin of 12.6% against 1.3%.
More: Neuronetics earnings · how Neuronetics makes money · InfuSystem Holdings earnings · how InfuSystem Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 8-K filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.